ClinicalTrials.Veeva

Menu

COVID-19 Vaccination Detoxification in LDL-C

Y

Yang I. Pachankis

Status and phase

Active, not recruiting
Phase 1

Conditions

COVID-19 Respiratory Infection
COVID-19 Vaccine Adverse Reaction
COVID-19 Post-Intensive Care Syndrome
COVID-19-Associated Thromboembolism
COVID-19-Associated Stroke
COVID-19 Stress Syndrome

Treatments

Combination Product: Atorvastatin Calcium Tablets

Study type

Interventional

Identifiers

NCT05839236
SARSCoVVAXDetox

Details and patient eligibility

About

The study hypothesizes that SARS-CoV-2 vaccination poisoning hibernates in human host in Low Density Lipoprotein Cholesterol (LDL-C). The clinical trial is a follow-up from the intervention trial with NCT number NCT05711810. It tests the use of Atorvastatin Calcium Tablets for detoxification and prevention of blood acidification, and the use of the Chinese herb compounded Anti-Viral Granules for the detoxification in the endocrine system.

Enrollment

1 patient

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • People who received COVID-19 vaccinations, or experiencing long-COVID.

Exclusion criteria

  • People with moderate and severe liver dysfunctions.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

1 participants in 1 patient group

LDL-C Detox
Experimental group
Description:
The participant is continued from the trial NCT05711810. The follow-up study is separately registered for the etiological evidence from vaccine poisoning. With the prior study's angiotensin-converting enzyme receptor inhibition therapy reaching desired power level and outcome, the participant's blood pressure. has dropped to normal range in a steady state without signs of sudden death risks. The separate study defines the treatment medicines in NCT05711810 as rescue medicines for discretions, and experiments with Atorvastatin Calcium Tablets with 20 mg per day, and Chinese herb compounded Anti-Viral Granules 12 g (total) in 3 times per day. The main ingredients for Anti-Viral Granules are the roots of Isatis indigotica L., Forsythia suspensa, Gypsum, Common Anemarrhena, Reed Rhizome, Rehmannia glutinosa, Patchouli, Tatarinow Sweerflag Rhizome, and Curcuma aromatica. They're mixed with dextrin, Sodium cyclamate, patchouli oil, peppermint oil, and angelica dahurica tincture.
Treatment:
Combination Product: Atorvastatin Calcium Tablets

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems